BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine https://www.biorxiv.org/content/10.1101/2023.03.21.533720v1?med=mas
BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine https://www.biorxiv.org/content/10.1101/2023.03.21.533720v1?med=mas